# NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

> **NCT07739290** · NA · NOT_YET_RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide (NAM)
- **DIETARY_SUPPLEMENT:** Placebo control

## Key facts

- **NCT ID:** NCT07739290
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07739290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07739290, "NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07739290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*